Literature DB >> 21966545

Role of α(5)β(1) Integrin Up-regulation in Radiation-Induced Invasion by Human Pancreatic Cancer Cells.

Hongren Yao1, Zhao-Zhu Zeng, Kevin S Fay, Donna M Veine, Evan D Staszewski, Meredith Morgan, Kari Wilder-Romans, Terence M Williams, Aaron C Spalding, Edgar Ben-Josef, Donna L Livant.   

Abstract

RADIOTHERAPY IS USED IN THE MANAGEMENT OF PANCREATIC CANCER BECAUSE OF ITS HIGH PROPENSITY FOR LOCOREGIONAL RELAPSE: one third of patients succumb to localized disease. Thus, strategies to improve the efficacy of radiotherapy in pancreatic cancer are important to pursue. We used naturally serum-free, selectively permeable basement membranes and confocal microscopy of fluorescent antibody-stained human Panc-1, MiaPaCa-2, and BxPC-3 pancreatic cancer cell lines to investigate the effects of ionizing radiation on α(5)β(1) integrin fibronectin receptor expression and on α(5)β(1)-mediated invasion. We report that radiation rapidly induces pancreatic cancer cell invasion, and that radiation-induced invasion is caused by up-regulation of α(5)β(1) integrin fibronectin receptors by transcriptional and/or postendocytic recycling mechanisms. We also report that radiation causes α(5)β(1) up-regulation in Panc-1, MiaPaCa-2, and BxPC-3 tumor xenografts and that upregulated α(5)β(1) colocalizes with upregulated early or late endosomes in Panc-1 or BxPC-3 tumors, respectively, although it may colocalize significantly with both endosome types in MiaPaCa-2 tumors. Our results suggest that systemic inhibition of α(5)β(1)-mediated invasion might be an effective way to reduce radiation-induced pancreatic cancer cell invasion, thereby improving the efficacy of radiotherapy.

Entities:  

Year:  2011        PMID: 21966545      PMCID: PMC3162303          DOI: 10.1593/tlo.11133

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  44 in total

1.  Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells.

Authors:  M Wu; G K Arimura; A A Yunis
Journal:  Biochemistry       Date:  1977-05-03       Impact factor: 3.162

2.  Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas.

Authors:  M Lieber; J Mazzetta; W Nelson-Rees; M Kaplan; G Todaro
Journal:  Int J Cancer       Date:  1975-05-15       Impact factor: 7.396

3.  Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation.

Authors:  Hongren Yao; Donna M Veine; Zhao-Zhu Zeng; Kevin S Fay; Evan D Staszewski; Donna L Livant
Journal:  Clin Exp Metastasis       Date:  2010-03-26       Impact factor: 5.150

4.  Defining the topology of integrin alpha5beta1-fibronectin interactions using inhibitory anti-alpha5 and anti-beta1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the alpha5 subunit.

Authors:  A P Mould; J A Askari; S i Aota; K M Yamada; A Irie; Y Takada; H J Mardon; M J Humphries
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

Review 5.  Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.

Authors:  Bryan W Chang; Eduardo Siccion; Muhammad Wasif Saif
Journal:  JOP       Date:  2010-07-05

6.  The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation.

Authors:  Hongren Yao; Donna M Veine; Kevin S Fay; Evan D Staszewski; Zhao-Zhu Zeng; Donna L Livant
Journal:  Breast Cancer Res Treat       Date:  2010-03-19       Impact factor: 4.872

7.  DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Authors:  Christine A Iacobuzio-Donahue; Baojin Fu; Shinichi Yachida; Mingde Luo; Hisashi Abe; Clark M Henderson; Felip Vilardell; Zheng Wang; Jesse W Keller; Priya Banerjee; Joseph M Herman; John L Cameron; Charles J Yeo; Marc K Halushka; James R Eshleman; Marian Raben; Alison P Klein; Ralph H Hruban; Manuel Hidalgo; Daniel Laheru
Journal:  J Clin Oncol       Date:  2009-03-09       Impact factor: 44.544

8.  Ionizing radiation modulates cell surface integrin expression and adhesion of COLO-320 cells to collagen and fibronectin in vitro.

Authors:  Viktor Meineke; Klaus-Peter Gilbertz; Karen Schilperoort; Nils Cordes; Andreas Sendler; Tilo Moede; Dirk van Beuningen
Journal:  Strahlenther Onkol       Date:  2002-12       Impact factor: 3.621

9.  Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression.

Authors:  Santhi Konduri; Jimmie Colon; Cheryl H Baker; Stephen Safe; James L Abbruzzese; Ala Abudayyeh; Md Riyaz Basha; Maen Abdelrahim
Journal:  Mol Cancer Ther       Date:  2009-03-03       Impact factor: 6.261

10.  Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma.

Authors:  Kenneth L van Golen; LiWei Bao; George J Brewer; Kenneth J Pienta; Jeffrey M Kamradt; Donna L Livant; Sofia D Merajver
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

View more
  20 in total

Review 1.  Integrins and metastasis.

Authors:  Kirat Kumar Ganguly; Sekhar Pal; Shuvojit Moulik; Amitava Chatterjee
Journal:  Cell Adh Migr       Date:  2013-04-05       Impact factor: 3.405

2.  Regulation of ionizing radiation-induced adhesion of breast cancer cells to fibronectin by alpha5beta1 integrin.

Authors:  Shin Hee Lee; Huiwen Cheng; Ye Yuan; Shiyong Wu
Journal:  Radiat Res       Date:  2014-05-01       Impact factor: 2.841

3.  A D-amino acid containing peptide as a potent, noncovalent inhibitor of α5β1 integrin in human prostate cancer invasion and lung colonization.

Authors:  Donna M Veine; Hongren Yao; Daniel R Stafford; Kevin S Fay; Donna L Livant
Journal:  Clin Exp Metastasis       Date:  2014-01-25       Impact factor: 5.150

4.  Long-term Tumor Adaptation after Radiotherapy: Therapeutic Implications for Targeting Integrins in Prostate Cancer.

Authors:  Iris Eke; Adeola Y Makinde; Molykutty J Aryankalayil; Jessica L Reedy; Deborah E Citrin; Sunita Chopra; Mansoor M Ahmed; C Norman Coleman
Journal:  Mol Cancer Res       Date:  2018-07-24       Impact factor: 5.852

5.  Recombinant disintegrin (r-Cam-dis) from Crotalus adamanteus inhibits adhesion of human pancreatic cancer cell lines to laminin-1 and vitronectin.

Authors:  Montamas Suntravat; Henriquez S Barret; Cameron A Jurica; Sara E Lucena; John C Perez; Elda E Sánchez
Journal:  J Venom Res       Date:  2015-04-26

6.  Lung cancer cells that survive ionizing radiation show increased integrin α2β1- and EGFR-dependent invasiveness.

Authors:  Xue Li; Seiichiro Ishihara; Motoaki Yasuda; Takeshi Nishioka; Takeomi Mizutani; Masayori Ishikawa; Kazushige Kawabata; Hiroki Shirato; Hisashi Haga
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

7.  Carbon ion irradiation of the human prostate cancer cell line PC3: a whole genome microarray study.

Authors:  Annelies Suetens; Marjan Moreels; Roel Quintens; Sabina Chiriotti; Kevin Tabury; Arlette Michaux; Vincent Grégoire; Sarah Baatout
Journal:  Int J Oncol       Date:  2014-02-03       Impact factor: 5.650

8.  Quantum dots for cancer research: current status, remaining issues, and future perspectives.

Authors:  Min Fang; Chun-Wei Peng; Dai-Wen Pang; Yan Li
Journal:  Cancer Biol Med       Date:  2012-09       Impact factor: 4.248

9.  Dose- and time-dependent gene expression alterations in prostate and colon cancer cells after in vitro exposure to carbon ion and X-irradiation.

Authors:  Annelies Suetens; Marjan Moreels; Roel Quintens; Els Soors; Jasmine Buset; Sabina Chiriotti; Kevin Tabury; Vincent Gregoire; Sarah Baatout
Journal:  J Radiat Res       Date:  2014-09-04       Impact factor: 2.724

Review 10.  Radiation oncology in vitro: trends to improve radiotherapy through molecular targets.

Authors:  Natália Feofanova; Jony Marques Geraldo; Lídia Maria de Andrade
Journal:  Biomed Res Int       Date:  2014-09-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.